Lea en español


Xarelto (chemical name Rivaroxaban) is an anti-coagulant manufactured by Bayer typically prescribed for people who are at risk for nonhemorrhagic strokes or embolisms. It has also been FDA approved for use during total knee or hip replacement surgery, as well as non-valvular atrial fibrillation. The FDA first approved Rivaroxaban for use in the United States in 2011.

Because it is an anticoagulant, Xarelto poses a serious risk of uncontrolled bleeding, including internal bleeding. At present, there is no known way to reverse the effects of Xarelto, which may be active for 8-12 hours. The FDA has also received reports of liver toxicity tied to use of Xarelto and has required that the package contain a warning not to discontinue without talking to a physician, as the likelihood of stroke can increase dramatically.

If you or someone you love has suffered injury after using Xarelto, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.

Defective Drugs & Medical Devices Topics

Latest Articles

FCC Votes to End Net Neutrality

Most people can agree that the internet is playing an increasingly important role in our everyday li…

03 Jan 2018, Wednesday

Merry Christmas From GetLegal

22 Dec 2017, Friday

Defamation: What You Need to Know

With the rise of social media, there is no longer a traditional “reasonable expectation of privacy…

15 Dec 2017, Friday